Cargando…
Treatment response assessment with (R)-[(11)CPAQ PET in the MMTV-PyMT mouse model of breast cancer
BACKGROUND: The goal of the study was to assess the potential of the vascular endothelial growth factor receptor (VEGFR)-2-targeting carbon-11 labeled (R)-N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-3-piperidinyl)methoxy)-4-quinazolineamine ((R)-[(11)C]PAQ) as a positron emission tomography (P...
Autores principales: | Tegnebratt, T., Lu, L., Eksborg, S., Chireh, A., Damberg, P., Nikkhou-Aski, S., Foukakis, T., Rundqvist, H., Holmin, S., Kuiper, R. V., Samen, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882477/ https://www.ncbi.nlm.nih.gov/pubmed/29616369 http://dx.doi.org/10.1186/s13550-018-0380-x |
Ejemplares similares
-
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model
por: Cai, Ying, et al.
Publicado: (2017) -
MRCKα Is Dispensable for Breast Cancer Development in the MMTV-PyMT Model
por: Kwa, Mei Qi, et al.
Publicado: (2021) -
A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice
por: Mohammad Mirzaei, Navid, et al.
Publicado: (2022) -
Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model
por: Roselli, Séverine, et al.
Publicado: (2014) -
Biomarkers of Residual Disease, Disseminated Tumor Cells, and Metastases in the MMTV-PyMT Breast Cancer Model
por: Franci, Christian, et al.
Publicado: (2013)